Những yếu tố dự đoán cải thiện sau liệu pháp sốc điện ở bệnh nhân Parkinson có triệu chứng "on-off"

Agnoli, A., Falaschi, P., Baldassarre, M., Rocco, A., Delroscio, S., D'Urso, R., Ruggieri, S.: Neuroendocrine approach in parkinsonian syndromes. In: Progress in Psychoneuroendocrinology, pp. 315–324. Amsterdam-New York-Oxford: Elsevier/North-Holland Biomedical Press. 1980. Andén, N.-E., Rubenson, A., Fuxe, K., Hökfelt, T.: Evidence for dopamine receptor stimulation by apomorphine. J. Pharm. Pharmacol.19, 627 to 629 (1967). Balldin, J., Bolle, P., Edén, S., Eriksson, E., Modigh, K.: Effects of electroconvulsive therapy on growth hormone secretion induced by monoamine receptor agonists in reserpine-pretreated rats. Psychoneuroendocrinology5, 329–337 (1980 a). Balldin, J., Edén, S., Granérus, A.-K., Modigh, K., Svanborg, A., Wålinder, J., Wallin, L.: Electroconvulsive therapy in Parkinson's syndrome with “on-off” phenomenon. J. Neural Transm.47, 11–21 (1980 b). Barbeau, A.: The clinical physiology of side effects in long-term L-dopa treatment. In: Advances in Neurology (McDowell, F. H., Barbeau, A., eds.), Vol. 5, pp. 347–365. New York: Raven Press. 1974. Björntorp, P., Holm, G., Jacobsson, B., Schiller-de Jounge, K., Lundberg, P. A., Sjöström, L., Smith, U., Sullivan, L.: Physical training in human hyperplastic obesity. IV. Effects on the hormonal status. Metabolism26, 319–328 (1977). Check, W. A.: Drug holidays for patients with parkinsonism. J. Am. Med. Ass.242, 17–21 (1979). Cronholm, B., Ottosson, J.-O.: Experimental studies of the therapeutic action of electroconvulsive therapy in endogenous depression: The role of electric stimulation and of the seizure studied by variation of stimulus and modification by lidocaine of seizure discharge. Acta Psychiatr. Neurol. Scand.35, Suppl. 145, 69–97 (1960). Direnfeld, L., Spero, L., Marotta, J., Seeman, P.: The L-dopa on-off effect in Parkinson disease: Treatment by transient drug withdrawal and dopamine receptor resensitization. Ann. Neurol.4, 573–575 (1978). Edén, S., Modigh, K.: Effects of apomorphine and clonidine on rat plasma growth hormone after pretreatment with reserpine and electroconvulsive shocks. Brain Res.129, 379–384 (1977). Evans, J. P., Grahame-Smith, D. G., Green, A. R., Tordoff, A. F. C.: Electroconvulsive shock increases the behavioural responses of rats to brain 5-hydroxytryptamine accumulation and central nervous system stimulant drugs. Br. J. Pharmacol.56, 193–199 (1976). Fink, M.: Risks of convulsive therapy. In: Convulsive Therapy: Theory and Practice (Fink, M., ed.), pp. 41–50. New York: Raven Press. 1979. Gold, L., Chiarello, C. J.: The prognostic value of clinical findings in cases treated with electric shock. J. Nerv. Ment. Dis.100, 577–583 (1944). Granérus, A.-K.: Factors influencing the occurrence of “on-off” symptoms during long-term treatment with L-dopa. Acta Med. Scand.203, 75–85 (1978). Granérus, A.-K., Carlsson, A., Svanborg, A.: The aging neuron — influence on symptomatology and therapeutic response in Parkinson's syndrome. In: Advances in Neurology (Poirier, L. J., Sourkes, T. L., Bédard, P. J., eds.), pp. 327–334. New York: Raven Press. 1979. Granérus, A.-K., Steg, G., Svanborg, A.: Clinical analysis of factors influencing L-dopa treatment of Parkinson's syndrome. Acta Med. Scand.192, 1–11 (1972). Kendall, M. G.: Rank correlation methods. London: Griffin. 1970. Lee, T., Seeman, P., Rajput, A., Farley, I. J., Hornykiewicz, O.: Receptor basis for dopaminergic supersensitivity in Parkinson's disease. Nature273, 59–60 (1978). Lehmann, E. L.: Non-parametric statistical methods based on ranks. San Francisco: McGraw-Hill. 1975. Markham, C. H.: The “on-off” side effect of L-dopa. In: Advances in Neurology (McDowell, F. H., Barbeau, A., eds.), Vol. 5, pp. 387–396. New York: Raven Press. 1974. Modigh, K.: Electroconvulsive shock and postsynaptic catecholamine effects: increased psychomotor stimulant action of apomorphine and clonidine in reserpine pretreated mice by repeated ECS. J. Neural Transm.36, 19–32 (1975). Ottosson, J.-O.: Electroconvulsive therapy of endogenous depression: An analysis of the influence of various factors on the efficacy of therapy. J. Ment. Sci.108, 694–703 (1962). Quik, M., Spokes, E. G., Mackay, A. V. P., Bannister, R.: Alterations in (3H)spiperone binding in human caudate nucleus, substantia nigra and frontal cortex in the Shy-Drager syndrome and Parkinson's disease. J. Neurol. Sci.43, 429–437 (1979). Rinne, U. K.: Recent advances in research on parkinsonism. Acta Neurol. Scand.57, Suppl. 67, 77–113 (1978). Roberts, J. M.: Prognostic factors in the electroshock treatment of depressive states: II. The application of specific tests. J. Ment. Sci.105, 703–713 (1959). Shibuya, M.: Dopamine-sensitive adenylate cyclase activity in the striatum in Parkinson's disease. J. Neural Transm.44, 287–295 (1979). Sweet, R. D., McDowell, F. H.: The “on-off” response to chronic L-dopa treatment of parkinsonism. Adv. Neurol.5, 331–338 (1974). Ward, C., Stern, G. M., Pratt, R. T. C., McKenna, P.: Electroconvulsive therapy in parkinsonian patients with the “on-off” syndrome. J. Neural Transm.49, 133–135 (1980). Weckowicz, T. E., Younge, K. A., Cropley, A. J., Muir, W.: Objective therapy predictors in depression: A multivariate approach. J. Clin. Psychol.27, Suppl., 3–29 (1971). Weiner, R. D.: The psychiatric use of electrically induced seizures. Am. J. Psychiatry136, 12, 1507–1517 (1979). Åsberg, M., Kragh-Sørensen, P., Mindham, R. H. S., Tuck, R. J.: International reliability and communicability of a rating scale for depression. Psychol. Med.3, 458–465 (1973).